For Adults With Active Ankylosing Spondylitis.
For Adults With Moderate to Severe Plaque Psoriasis.
For Adults With Active Psoriatic Arthritis.
Plaque psoriasis is a prevalent chronic disease, characterized by thick and extensive skin lesions, called plaques, known to cause itching, scaling, and pain. Whether your condition is moderate or severe, you know plaque psoriasis can take a toll. According to the National Psoriasis Foundation, nearly 60 percent of people with psoriasis reported their disease to be a large problem for them.
COVERAGE AND SEVERITY
Plaque psoriasis affects people differently, with coverage ranging from mild to severe. The severity of psoriasis may also be measured by the location of the plaques and how it affects you.
*COSENTYX is only indicated for moderate to severe plaque psoriasis in adults.
Less than 3% of the body has psoriasis
3% to 10% of the body has psoriasis
More than 10% of the body has psoriasis
Drag to show example of body surface coverage. Plaque location may vary.
Plaque psoriasis is the result of an overactive immune system. While the specific causes of plaque psoriasis are not fully known, it is believed that there are multiple proteins in your immune system, including IL-17A, that may play a role in inflammation and skin plaque growth.
“I literally had it from head to toe. It was in my scalp, in my ears, everywhere in between.” – SherrieSee Sherrie’s story
We know it's tempting to stop taking your medication if you're seeing results, and even easier to give up if your treatment isn't meeting your expectations. Moderate to severe plaque psoriasis is a chronic disease of the immune system. Therefore, it's important for you to follow the treatment plan outlined by your doctor and to follow up with him/her regularly.
Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.
COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:
COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections.
New cases of inflammatory bowel disease or "flare-ups" can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn’s disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.
Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; or skin rash. If you have a severe allergic reaction, do not give another injection of COSENTYX.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of your medicines to show your doctor and pharmacist when you get a new medicine.
How should I use COSENTYX?
See the detailed Instructions for Use that comes with your COSENTYX for information on how to prepare and inject a dose of COSENTYX, and how to properly throw away (dispose of) used COSENTYX Sensoready® pens and prefilled syringes.
The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory infections. These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
COSENTYX® (secukinumab) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light, alone or with systemic therapy).